Skip to main content
PMC home page
American Journal of Public Health logoLink to American Journal of Public Health
. 1995 Aug;85(8 Pt 1):1128–1132. doi: 10.2105/ajph.85.8_pt_1.1128

Hormonal replacement therapy and morbidity and mortality in a prospective study of postmenopausal women.

A R Folsom 1, P J Mink 1, T A Sellers 1, C P Hong 1, W Zheng 1, J D Potter 1
PMCID: PMC1615815  PMID: 7625511

Abstract

We assessed the association of hormonal replacement therapy with mortality and incidence of multiple diseases in over 40,000 postmenopausal women followed for 6 years as part of the Iowa Women's Health Study. Compared with women who never used hormone replacement therapy, current users had multivariate adjusted relative risks (RR) as follows: total mortality (RR = 0.78; 95% confidence interval [CI] = 0.65, 0.94), coronary heart disease mortality (RR = 0.74; 95% CI = 0.48, 1.12), endometrial cancer incidence (RR = 4.3; 95% CI = 2.7, 6.9), breast cancer incidence (RR = 1.23; 95% CI = 0.99, 1.55), colon cancer incidence (RR = 0.72; 95% CI = 0.46, 1.12), and hip fracture incidence (RR = 0.53; 95% CI = 0.31, 0.91).

Full text

PDF
1128

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barrett-Connor E. L. The risks and benefits of long-term estrogen replacement therapy. Public Health Rep. 1989 Sep-Oct;104 (Suppl):62–65. [PMC free article] [PubMed] [Google Scholar]
  2. Barzel U. S. Estrogens in the prevention and treatment of postmenopausal osteoporosis: a review. Am J Med. 1988 Dec;85(6):847–850. doi: 10.1016/s0002-9343(88)80033-0. [DOI] [PubMed] [Google Scholar]
  3. Belchetz P. E. Hormonal treatment of postmenopausal women. N Engl J Med. 1994 Apr 14;330(15):1062–1071. doi: 10.1056/NEJM199404143301508. [DOI] [PubMed] [Google Scholar]
  4. Chute C. G., Willett W. C., Colditz G. A., Stampfer M. J., Rosner B., Speizer F. E. A prospective study of reproductive history and exogenous estrogens on the risk of colorectal cancer in women. Epidemiology. 1991 May;2(3):201–207. doi: 10.1097/00001648-199105000-00007. [DOI] [PubMed] [Google Scholar]
  5. Colditz G. A., Egan K. M., Stampfer M. J. Hormone replacement therapy and risk of breast cancer: results from epidemiologic studies. Am J Obstet Gynecol. 1993 May;168(5):1473–1480. doi: 10.1016/s0002-9378(11)90784-4. [DOI] [PubMed] [Google Scholar]
  6. Cotton P. Women's health initiative leads way as research begins to fill gender gaps. JAMA. 1992 Jan 22;267(4):469-70, 473. [PubMed] [Google Scholar]
  7. Davis F. G., Furner S. E., Persky V., Koch M. The influence of parity and exogenous female hormones on the risk of colorectal cancer. Int J Cancer. 1989 Apr 15;43(4):587–590. doi: 10.1002/ijc.2910430409. [DOI] [PubMed] [Google Scholar]
  8. Falkeborn M., Persson I., Terént A., Adami H. O., Lithell H., Bergström R. Hormone replacement therapy and the risk of stroke. Follow-up of a population-based cohort in Sweden. Arch Intern Med. 1993 May 24;153(10):1201–1209. [PubMed] [Google Scholar]
  9. Finucane F. F., Madans J. H., Bush T. L., Wolf P. H., Kleinman J. C. Decreased risk of stroke among postmenopausal hormone users. Results from a national cohort. Arch Intern Med. 1993 Jan 11;153(1):73–79. [PubMed] [Google Scholar]
  10. Folsom A. R., Kaye S. A., Sellers T. A., Hong C. P., Cerhan J. R., Potter J. D., Prineas R. J. Body fat distribution and 5-year risk of death in older women. JAMA. 1993 Jan 27;269(4):483–487. [PubMed] [Google Scholar]
  11. Furner S. E., Davis F. G., Nelson R. L., Haenszel W. A case-control study of large bowel cancer and hormone exposure in women. Cancer Res. 1989 Sep 1;49(17):4936–4940. [PubMed] [Google Scholar]
  12. Gangar K. F., Vyas S., Whitehead M., Crook D., Meire H., Campbell S. Pulsatility index in internal carotid artery in relation to transdermal oestradiol and time since menopause. Lancet. 1991 Oct 5;338(8771):839–842. doi: 10.1016/0140-6736(91)91500-t. [DOI] [PubMed] [Google Scholar]
  13. Gerhardsson de Verdier M., London S. Reproductive factors, exogenous female hormones, and colorectal cancer by subsite. Cancer Causes Control. 1992 Jul;3(4):355–360. doi: 10.1007/BF00146889. [DOI] [PubMed] [Google Scholar]
  14. Grady D., Rubin S. M., Petitti D. B., Fox C. S., Black D., Ettinger B., Ernster V. L., Cummings S. R. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med. 1992 Dec 15;117(12):1016–1037. doi: 10.7326/0003-4819-117-12-1016. [DOI] [PubMed] [Google Scholar]
  15. Hemminki E., Kennedy D. L., Baum C., McKinlay S. M. Prescribing of noncontraceptive estrogens and progestins in the United States, 1974-86. Am J Public Health. 1988 Nov;78(11):1479–1481. doi: 10.2105/ajph.78.11.1479. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Henderson B. E., Paganini-Hill A., Ross R. K. Decreased mortality in users of estrogen replacement therapy. Arch Intern Med. 1991 Jan;151(1):75–78. [PubMed] [Google Scholar]
  17. Henrich J. B. The postmenopausal estrogen/breast cancer controversy. JAMA. 1992 Oct 14;268(14):1900–1902. [PubMed] [Google Scholar]
  18. Lippman M. E., Dickson R. B., Bates S., Knabbe C., Huff K., Swain S., McManaway M., Bronzert D., Kasid A., Gelmann E. P. 8th San Antonio Breast Cancer Symposium--Plenary lecture. Autocrine and paracrine growth regulation of human breast cancer. Breast Cancer Res Treat. 1986;7(2):59–70. doi: 10.1007/BF01806790. [DOI] [PubMed] [Google Scholar]
  19. McMichael A. J., Potter J. D. Host factors in carcinogenesis: certain bile-acid metabolic profiles that selectively increase the risk of proximal colon cancer. J Natl Cancer Inst. 1985 Aug;75(2):185–191. [PubMed] [Google Scholar]
  20. Meilahn E. N. Hemostatic factors and risk of cardiovascular disease in women. An overview. Arch Pathol Lab Med. 1992 Dec;116(12):1313–1317. [PubMed] [Google Scholar]
  21. Meilahn E. N., Kuller L. H., Matthews K. A., Kiss J. E. Hemostatic factors according to menopausal status and use of hormone replacement therapy. Ann Epidemiol. 1992 Jul;2(4):445–455. doi: 10.1016/1047-2797(92)90094-7. [DOI] [PubMed] [Google Scholar]
  22. Nabulsi A. A., Folsom A. R., White A., Patsch W., Heiss G., Wu K. K., Szklo M. Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The Atherosclerosis Risk in Communities Study Investigators. N Engl J Med. 1993 Apr 15;328(15):1069–1075. doi: 10.1056/NEJM199304153281501. [DOI] [PubMed] [Google Scholar]
  23. Peters R. K., Pike M. C., Chang W. W., Mack T. M. Reproductive factors and colon cancers. Br J Cancer. 1990 May;61(5):741–748. doi: 10.1038/bjc.1990.166. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Posthuma W. F., Westendorp R. G., Vandenbroucke J. P. Cardioprotective effect of hormone replacement therapy in postmenopausal women: is the evidence biased? BMJ. 1994 May 14;308(6939):1268–1269. doi: 10.1136/bmj.308.6939.1268. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Potter J. D., McMichael A. J. Large bowel cancer in women in relation to reproductive and hormonal factors: a case-control study. J Natl Cancer Inst. 1983 Oct;71(4):703–709. [PubMed] [Google Scholar]
  26. Rosano G. M., Sarrel P. M., Poole-Wilson P. A., Collins P. Beneficial effect of oestrogen on exercise-induced myocardial ischaemia in women with coronary artery disease. Lancet. 1993 Jul 17;342(8864):133–136. doi: 10.1016/0140-6736(93)91343-k. [DOI] [PubMed] [Google Scholar]
  27. Sellers T. A., Kushi L. H., Potter J. D., Kaye S. A., Nelson C. L., McGovern P. G., Folsom A. R. Effect of family history, body-fat distribution, and reproductive factors on the risk of postmenopausal breast cancer. N Engl J Med. 1992 May 14;326(20):1323–1329. doi: 10.1056/NEJM199205143262004. [DOI] [PubMed] [Google Scholar]
  28. Stampfer M. J., Colditz G. A. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med. 1991 Jan;20(1):47–63. doi: 10.1016/0091-7435(91)90006-p. [DOI] [PubMed] [Google Scholar]
  29. Stampfer M. J., Colditz G. A., Willett W. C., Manson J. E., Rosner B., Speizer F. E., Hennekens C. H. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study. N Engl J Med. 1991 Sep 12;325(11):756–762. doi: 10.1056/NEJM199109123251102. [DOI] [PubMed] [Google Scholar]
  30. Walsh B. W., Schiff I., Rosner B., Greenberg L., Ravnikar V., Sacks F. M. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med. 1991 Oct 24;325(17):1196–1204. doi: 10.1056/NEJM199110243251702. [DOI] [PubMed] [Google Scholar]
  31. Weiss N. S., Daling J. R., Chow W. H. Incidence of cancer of the large bowel in women in relation to reproductive and hormonal factors. J Natl Cancer Inst. 1981 Jul;67(1):57–60. [PubMed] [Google Scholar]
  32. Weiss N. S., Ure C. L., Ballard J. H., Williams A. R., Daling J. R. Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen. N Engl J Med. 1980 Nov 20;303(21):1195–1198. doi: 10.1056/NEJM198011203032102. [DOI] [PubMed] [Google Scholar]
  33. Whitehead M. I. The effects of oestrogens and progestogens on the postmenopausal endometrium. Maturitas. 1978 Sep;1(2):87–98. doi: 10.1016/0378-5122(78)90015-4. [DOI] [PubMed] [Google Scholar]
  34. Whitehead M. I., Townsend P. T., Pryse-Davies J., Ryder T. A., King R. J. Effects of estrogens and progestins on the biochemistry and morphology of the postmenopausal endometrium. N Engl J Med. 1981 Dec 31;305(27):1599–1605. doi: 10.1056/NEJM198112313052701. [DOI] [PubMed] [Google Scholar]
  35. Wu A. H., Paganini-Hill A., Ross R. K., Henderson B. E. Alcohol, physical activity and other risk factors for colorectal cancer: a prospective study. Br J Cancer. 1987 Jun;55(6):687–694. doi: 10.1038/bjc.1987.140. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from American Journal of Public Health are provided here courtesy of American Public Health Association

RESOURCES